{"title":"糖尿病患者非医疗转换的立场","authors":"Larry Ellingson","doi":"10.15406/JDMDC.2017.04.00123","DOIUrl":null,"url":null,"abstract":"because they are manufactured from known chemicals and are characterized by their chemical equivalence making them virtually identical to the original branded medication. However, Non-Medical Switching has now been extended to biologic medications, such as insulin. The manufacturing processes for insulin use different cell lines, protein sources, as well as extraction and purification techniques. These are proprietary and often patented processes. The insulins may have similar abilities to lower blood glucose but they are not identical replacements.","PeriodicalId":92240,"journal":{"name":"Journal of diabetes, metabolic disorders & control","volume":"31 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2017-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Position on non-medical switching for diabetes patients\",\"authors\":\"Larry Ellingson\",\"doi\":\"10.15406/JDMDC.2017.04.00123\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"because they are manufactured from known chemicals and are characterized by their chemical equivalence making them virtually identical to the original branded medication. However, Non-Medical Switching has now been extended to biologic medications, such as insulin. The manufacturing processes for insulin use different cell lines, protein sources, as well as extraction and purification techniques. These are proprietary and often patented processes. The insulins may have similar abilities to lower blood glucose but they are not identical replacements.\",\"PeriodicalId\":92240,\"journal\":{\"name\":\"Journal of diabetes, metabolic disorders & control\",\"volume\":\"31 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-08-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of diabetes, metabolic disorders & control\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15406/JDMDC.2017.04.00123\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of diabetes, metabolic disorders & control","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/JDMDC.2017.04.00123","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Position on non-medical switching for diabetes patients
because they are manufactured from known chemicals and are characterized by their chemical equivalence making them virtually identical to the original branded medication. However, Non-Medical Switching has now been extended to biologic medications, such as insulin. The manufacturing processes for insulin use different cell lines, protein sources, as well as extraction and purification techniques. These are proprietary and often patented processes. The insulins may have similar abilities to lower blood glucose but they are not identical replacements.